Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The long-running dispute between cigarette maker Philip Morris International Inc. (PM - Analyst Report) and 19 U.S. states has come to an end. Other cigarette makers also reached an agreement and these companies, including Philip Morris, have agreed to pay $4 billion to the states under the 1998 anti smoking agreement.
The dispute was related to Non-Participating Manufacturer (NPM) adjustment provisions of the Master Settlement Agreement (MSA). Under this agreement, inked between 46 states and major tobacco players including Philip Morris, Reynolds American Inc. (RAI - Analyst Report) and Lorillard Inc. (LO - Analyst Report), the tobacco makers had agreed to pay the states for their tobacco-related health-care costs and also abide by the restrictions on advertising, marketing and selling cigarettes in these states.
The dispute arose over the amount of payment that these tobacco companies had to pay to the state governments, since they lost market share in these states to other companies who did not enter into the agreement.
The 19 states that reached the agreement are Alabama, Arizona, Arkansas, California, Georgia, Kansas, Louisiana, Michigan, Nebraska, Nevada, New Hampshire, New Jersey, North Carolina, Tennessee, Virginia, West Virginia, Wyoming, Puerto Rico and the District of Columbia.
The states have so far received $85 billion. According to the settlement, the 19 states will get their share of about $4 billion that was paid into a disputed payments account. In return, the tobacco giants will receive credits against future payments to the states.
Philip Morris will get 28% of credit to the companies that were original participants in the settlement. It is estimated to total approximately $450.0 million, but it may vary depending on various factors. However, the company said that it will continue negotiations with states that were not part of the new agreement.
Currently, we have a Neutral recommendation on the stock. Philip Morris holds a Zacks #3 Rank (short term Hold rating). Philip Morris reported adjusted third quarter 2012 earnings per share of $1.45, surpassing the year-ago quarter’s earnings by 5.8%, excluding currency. Earnings beat the Zacks Consensus Estimate of $1.39.
Get the full Analyst Report on PM - FREE
Get the full Analyst Report on RAI - FREE
Get the full Analyst Report on LO - FREE